Sofosbuvir/ledipasvir for 6 weeks cures HCV in HIV-positive people with acute HCV if viral load is low
Large-scale household TB screening shows feasibility in PopART trial
Almost-certain case of PrEP failure due to drug resistance reported at CROI 2016
Early antiretroviral therapy reduces the risk of infection-related cancers
HIV in the brain: new tools and treatment to keep your mind beautiful
Removing clinic barriers to rapid initiation of ART in Uganda enables 70% to start on the same day
Dolutegravir safe and highly effective in older children
Long-acting PrEP injection tolerable and acceptable for male volunteers, but dose adjustment needed
Tenofovir alafenamide PrEP protects monkeys from infection, but rectal and vaginal levels in humans may be too low
